首页> 外文期刊>Journal of Clinical and Diagnostic Research >Utility of Serological Tests in the Era of Molecular Testing for Diagnosis of Human Brucellosis in Endemic Area with Limited Resources
【24h】

Utility of Serological Tests in the Era of Molecular Testing for Diagnosis of Human Brucellosis in Endemic Area with Limited Resources

机译:血清学检测在分子检测时代诊断资源有限的地方性地区布鲁氏菌病中的应用

获取原文
           

摘要

Background: The culture has always been the gold standard test for diagnosis of human brucellosis but the conventional Brucella diagnostic tests viz. serology and culture are often beset with poor specificity & sensitivity respectively. The culture positivity rates for Brucella vary from 92% for bone marrow to 10% for non-blood samples and also dependent on the type of sample. The primary immune-determinant for Brucella species is the cell wall surface lipopolysaccharide, which is antigenically similar to other gram-negative rods. Hence, Brucella serological tests cross react with Escherichia coli 0116 and 0157, Salmonella urbana, Yersinia enterocolitica 0:9, Vibrio cholerae, Xanthomonas maltophilia and Afipia clevellandensis infections, which are common in developing countries also having higher incidence of brucellosis. Aim: The aim of the study was evaluation of conventional serological techniques and PCR for diagnosis of human brucellosis in and around north Karnataka which is endemic for brucellosis and patients often present with elevated base line antibody titers and confounding clinical manifestations. Materials and Methods: Blood/serum samples of 400 patients suffering from acute undifferentiated fever (AUF) were subjected to culture, Brucella slide agglutination test (SAT), standard tube agglutination test (STAT coupled with 2 ME) and PCR. Results: Of the 400 AUF patients, anti-Brucella antibodies were detected by SAT and STAT in serum of 35 and 34 patients respectively. IS711 gene for Brucella was identified in 32 patients by PCR. Twenty samples yielded Brucella in culture on biphasic medium with average incubation period of 9 days. All patients having titer of = 160IU / ml in STAT were found positive by PCR also. Conclusion: Brucella STAT corroborated well with PCR results in all those cases where antibodies were present at least one dilution above cut-off value of 80 IU/ml. We probably need to raise cut-off titers to =160 IU/ml because of endemic region. The SAT was upheld as very good quick, easy to perform and economical screening test for human brucellosis. SAT as rapid screening test and STAT as more definitive test can be very well adopted by laboratories working in resource scarce settings for diagnosis of human brucellosis in absence of PCR even for population with normally elevated antibodies levels due to residing in Brucella endemic areas.
机译:背景:文化一直是诊断人类布鲁氏菌病的金标准测试,但常规布鲁氏菌病诊断测试即是。血清学和文化常常被特异性和敏感性差的困扰。布鲁氏菌的培养阳性率从骨髓的92%到非血液样品的10%不等,还取决于样品的类型。布鲁氏菌属的主要免疫决定因素是细胞壁表面脂多糖,其抗原性类似于其他革兰氏阴性菌。因此,布鲁氏菌的血清学检测与大肠杆菌0116和0157,城市沙门氏菌,肠炎耶尔森氏菌0:9,霍乱弧菌,嗜麦芽糖单胞菌和克雷夫兰氏菌感染有交叉反应,在发展中国家,布鲁氏菌病的发病率也较高。目的:本研究的目的是评估卡纳塔克邦北部及其周围地区人类布鲁氏菌病的常规血清学技术和PCR诊断方法,该病是布鲁氏菌病的地方病,并且患者通常存在基线抗体滴度升高和临床表现混乱的情况。材料与方法:对400例急性未分化发热(AUF)患者的血液/血清样本进行培养,布鲁氏菌玻片凝集试验(SAT),标准试管凝集试验(STAT结合2ME)和PCR。结果:在400例AUF患者中,分别通过SAT和STAT检测了35例和34例患者血清中的抗Brucella抗体。通过PCR鉴定了32例布鲁氏菌的IS711基因。二十个样品在双相培养基上培养产生布鲁氏菌,平均潜伏期为9天。通过PCR也发现所有STAT滴度= 160IU / ml的患者均为阳性。结论:在所有抗体存在至少一个高于80 IU / ml临界值的稀释度的情况下,布鲁氏菌STAT与PCR结果的一致性很好。由于地方性地区的原因,我们可能需要将滴定度提高至= 160 IU / ml。 SAT被认为是对人类布鲁氏菌病非常好的快速,易于执行且经济的筛查测试。在资源匮乏地区工作的实验室可以很好地采用SAT作为快速筛选测试,而STAT作为更确定的测试,即使在布鲁氏菌流行地区由于抗体水平正常升高的人群,也可以在没有PCR的情况下诊断人类布鲁氏菌病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号